Identification of CTLA-4 isoforms produced by alternative splicing and their association with myasthenia gravis.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Immunology

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.clim.2008.05.006PMID 18595775
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4.

  2007cited by this paper
• Soluble CTLA-4 in autoimmune thyroid diseases: relationship with clinical status and possible role in the immune response dysregulation.

  2007cited by this paper
• CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden

  2007cited by this paper
• A molecular perspective of CTLA-4 function.

  2006cited by this paper
• Journal of Autoimmune Diseases BioMed Central

  2005cited by this paper
• Association of CTLA4 polymorphism with regulatory T cell frequency

  2005influential reference
• The soluble CTLA-4 receptor: a new marker in autoimmune diseases.

  2005cited by this paper
• B7-Independent Inhibition of T Cells by CTLA-41

  2005cited by this paper
• Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications

  2004cited by this paper
• An autoimmune disease-associated CTLA-4 splice variant lacking the B7 binding domain signals negatively in T cells.

  2004influential reference
• A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells

  2003cited by this paper
• Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

  2003influential reference
• Diversity of Clonal T Cell Proliferation Is Mediated by Differential Expression of CD152 (CTLA-4) on the Cell Surface of Activated Individual T Lymphocytes1

  2003cited by this paper
• Pre-mRNA splicing and human disease.

  2003cited by this paper
• A Stem Structure in Fibroblast Growth Factor Receptor 2 Transcripts Mediates Cell-Type-Specific Splicing by Approximating Intronic Control Elements

  2003cited by this paper
• CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis

  2002cited by this paper
• Detection of a novel specificity (CTLA-4) in ATG/TMG globulins and sera from ATG-treated leukemic patients1

  2002cited by this paper
• Epidemiology of Myasthenia gravis: A Population-Based Study in Stockholm, Sweden

  2002cited by this paper
• Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence.

  2002cited by this paper
• IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).

  2002cited by this paper
• Expression of CTLA‐4 by Human Monocytes

  2002cited by this paper
• Cellular Response to an Antisense-mediated Shift of Bcl-x Pre-mRNA Splicing and Antineoplastic Agents*

  2002cited by this paper
• Blockade of CD40 Ligand Suppresses Chronic Experimental Myasthenia Gravis by Down-Regulation of Th1 Differentiation and Up-Regulation of CTLA-41

  2001cited by this paper
• Anti-CTLA-4 Antibody Treatment Triggers Determinant Spreading and Enhances Murine Myasthenia Gravis1

  2001cited by this paper
• Modification of alternative splicing pathways as a potential approach to chemotherapy.

  2000cited by this paper
• Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease

  2000cited by this paper
• A native soluble form of CTLA-4.

  2000influential reference
• Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells.

  1999cited by this paper
• A soluble form of CTLA‐4 generated by alternative splicing is expressed by nonstimulated human T cells

  1999cited by this paper
• Neurexins: three genes and 1001 products.

  1998cited by this paper
• Characterization of multiple isoforms of protein 4.1R expressed during erythroid terminal differentiation.

  1998cited by this paper
• Directing alternative splicing: cast and scenarios.

  1996cited by this paper
• Regulation of surface and intracellular expression of CTLA4 on mouse T cells.

  1996cited by this paper
• The role of the thymus in myasthenia gravis.

  1994cited by this paper
• Alternative splicing in the control of gene expression.

  1989cited by this paper
• Developmentally induced, muscle-specific trans factors control the differential splicing of alternative and constitutive troponin T exons.

  1987cited by this paper
• Alternative splicing: a ubiquitous mechanism for the generation of multiple protein isoforms from single genes.

  1987cited by this paper

• The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies

  2025cites this paper
• PD-1IR2 promotes tumor evasion via deregulating CD8+ T cell function

  2025cites this paper
• Role of RNA Alternative Splicing in T Cell Function and Disease

  2023cites this paper
• Immunomodulatory Gene-Splicing Dysregulation in Tumorigenesis: Unmasking the Complexity

  2023cites this paper
• Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease

  2021cites this paper
• Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy

  2020cites this paper
• Association of Rs231775 Genetic Variant of Cytotoxic T-lymphocyte Associated Protein 4 with Alopecia Areata Disease in Males: A Case–Control Study

  2020cites this paper
• Signaling pathways of genetic variants and miRNAs in the pathogenesis of myasthenia gravis.

  2020cites this paper
• Association between CTLA-4 gene polymorphism and myasthenia gravis in a Chinese cohort.

  2019cites this paper
• Association of CTLA‐4 polymorphisms with increased risks of myasthenia gravis

  2018cites this paper
• CTLA-4 methylation regulates the pathogenesis of myasthenia gravis and the expression of related cytokines

  2018cites this paper
• A Sensitive Method for Detecting Peptide-specific CD4+ T Cell Responses in Peripheral Blood from Patients with Myasthenia Gravis

  2017cites this paper
• Understanding Human Autoimmunity and Autoinflammation Through Transcriptomics.

  2017cites this paper
• Abnormalities in alternative splicing in diabetes: therapeutic targets.

  2017cites this paper
• Implications of Epigenetics in Myasthenia Gravis

  2016cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Alternative splicing: the new frontier in diabetes research.

  2016cites this paper
• Alternative splicing: the new frontier in diabetes research

  2016cites this paper
• Myasthenia Gravis Induced by Ipilimumab in Patients With Metastatic Melanoma.

  2015cites this paper
• Complicating autoimmune diseases in myasthenia gravis: a review

  2015cites this paper
• Variation in the CTLA4 3′UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes

  2015cites this paper
• Genetic basis of myasthenia gravis - a comprehensive review.

  2014cites this paper
• Differential expression of alternative splice variants of CTLA4 in Kuwaiti autoimmune disease patients.

  2014cites this paper
• Differential expression of alternative splice variants of CTLA4 in Kuwaiti autoimmune disease patients.

  2014cites this paper
• RELATED AUTOIMMUNE DISORDERS

  2011cites this paper
• Genetic Factors Predisposing to Myasthenia Gravis and Related Autoimmune Disorders

  2010cites this paper
• CTLA4 CT60 Single-Nucleotide Polymorphism Is Associated with Slovenian Inflammatory Bowel Disease Patients and Regulates Expression of CTLA4 Isoforms

  2010cites this paper
• Alternative splicing in multiple sclerosis and other autoimmune diseases

  2010cites this paper
• Effect of cytotoxic T lymphocyte‐associated molecule 4 1661 gene polymorphism on its expression and transcription in ulcerative colitis

  2010cites this paper
• CTLA4 −1661A/G and 3′UTR long repeat polymorphisms are associated with ulcerative colitis and influence CTLA4 mRNA and protein expression

  2010cites this paper
• Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.

  2009cites this paper
• MECHANISMS IN ENDOCRINOLOGY Alternative splicing: the new frontier in diabetes research

  year unknowncites this paper